Mannkind (MNKD) EBIT Margin (2010 - 2026)

Mannkind (MNKD) reported EBIT Margin of 1.85% for Q1 2026, down 3030.0% year-over-year from 0.06% in Q1 2025, and up 73.08% quarter-over-quarter from 6.87% in Q4 2025.

Mannkind (MNKD) EBIT Margin (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 14 years of EBIT Margin data on file, last reported at 1.85% in Q1 2026.

  • EBIT Margin for Q1 2026 came in at 1.85%, down 3030.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.11% (down 2215.0% YoY), and the FY2025 annual result was 11.12%, down 1431.0% from the prior year.
  • EBIT Margin grew to 1.85% in Q1 2026 per MNKD's latest filing, from 6.87% in the prior quarter.
  • Over five years, EBIT Margin peaked at 34.51% in Q4 2024 and troughed at 6818.0% in Q2 2022.
  • A 5-year average of 405.72% and a median of 6.92% in 2025 frame the typical range for EBIT Margin.
  • The sharpest annual moves came in 2022 and 2023: EBIT Margin sank 677387 bps in 2022, then surged 682154 bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 35.47% in 2022, then surged by 138 bps to 13.44% in 2023, then jumped by 157 bps to 34.51% in 2024, then tumbled by 120 bps to 6.87% in 2025, then soared by 73 bps to 1.85% in 2026.
  • Business Quant data shows MNKD's EBIT Margin at 1.85% in Q1 2026, 6.87% in Q4 2025, and 23.01% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 38.10%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Mannkind 1.13 Bn 995.19 Mn 82.66 Mn -1.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.85%
Dec 31, 2025 -6.87%
Sep 30, 2025 23.01%
Jun 30, 2025 6.92%
Mar 31, 2025 28.45%
Dec 31, 2024 34.51%
Sep 30, 2024 18.21%
Jun 30, 2024 22.95%
Mar 31, 2024 25.24%
Dec 31, 2023 13.44%
Sep 30, 2023 9.94%
Jun 30, 2023 3.54%
Mar 31, 2023 -14.76%
Dec 31, 2022 -35.47%
Sep 30, 2022 -29.28%
Jun 30, 2022 -6,818.00%
Mar 31, 2022 -177.25%
Dec 31, 2021 -191.51%
Sep 30, 2021 -29.67%
Jun 30, 2021 -44.13%